Adial Pharmaceuticals Appoints New Chief Medical Officer
Ticker: ADIL · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1513525
| Field | Detail |
|---|---|
| Company | Adial Pharmaceuticals, Inc. (ADIL) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, personnel
TL;DR
Adial Pharma names Dr. Dean as CMO, bringing ALKS disorder expertise.
AI Summary
On July 9, 2025, Adial Pharmaceuticals, Inc. announced the appointment of Dr. William J. R. Dean as Chief Medical Officer. Dr. Dean brings extensive experience in drug development and clinical research, particularly in the field of alcohol use disorder, which is Adial's primary focus.
Why It Matters
The appointment of a new Chief Medical Officer with relevant expertise could signal a renewed focus on clinical development and regulatory strategy for Adial's pipeline, potentially impacting the company's future success.
Risk Assessment
Risk Level: medium — The appointment of a key executive is a significant event, but the filing itself does not contain financial or operational risks.
Key Players & Entities
- Adial Pharmaceuticals, Inc. (company) — Registrant
- Dr. William J. R. Dean (person) — Appointed Chief Medical Officer
- July 9, 2025 (date) — Date of Report
FAQ
What is the effective date of Dr. Dean's appointment?
The filing does not specify an exact effective date for Dr. Dean's appointment, but it was reported on July 9, 2025.
What is Adial Pharmaceuticals' primary focus area?
Adial Pharmaceuticals' primary focus is on the treatment of alcohol use disorder.
What is the principal executive office address for Adial Pharmaceuticals?
The principal executive offices are located at 4870 Sadler Road, Ste 300, Glen Allen, VA 23060.
What is the company's telephone number?
The company's telephone number is (804) 487-8196.
What is the Standard Industrial Classification code for Adial Pharmaceuticals?
The Standard Industrial Classification code is 2834, for Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 by Dr. William J. R. Dean regarding ADIAL PHARMACEUTICALS, INC. (ADIL).